Jameca Price, MD
Urogynecology and Reconstructive Pelvic Surgery · Tulsa, OKNPI 1780818575
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,606 of the $1,908 with a category attached, or 84.2%. 6 manufacturers reported payments, led by Coloplast at 55.6% of the total. Reporting peaked in 2024 at $525 and has fallen 78.2% since, to $115 in 2025.
Across 26 payments — averaging $73.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coloplast$1K
- Medtronic$417
- Axonics, Inc.$170
- AbbVie$121
- Intuitive Surgical$100
- Applied Medical Resources Corporation$40
What the payments were for
- Travel & lodging$28415%
- Food & beverage$1,60684%
- Education$171%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Coloplast | 9 | $1,060 |
| Medtronic | 7 | $417 |
| Axonics, Inc. | 2 | $170 |
| AbbVie(2 entities) | 6 | $121 |
| Intuitive Surgical | 1 | $100 |
| Applied Medical Resources Corporation | 1 | $40 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ALTIS$883
- INTERSTIM$328
- Axonics$140
- Da Vinci Surgical System$100
How this compares
Too few urogynecology and reconstructive pelvic surgery providers in Oklahomato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 91 | $46,819 |
| GemtesaVibegron | 26 | $21,077 |
| PremarinEstrogens, Conjugated | 16 | $7,162 |
| Estradiol | 77 | $3,974 |
| Trospium Chloride | 16 | $1,379 |
| Solifenacin Succinate | 47 | $1,292 |
| Tolterodine Tartrate ErTolterodine Tartrate | 14 | $433 |
| Metronidazole | 25 | $189 |
| Fluconazole | 14 | $112 |
| Celecoxib | 11 | $74 |
| Gabapentin | 17 | $66 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 11 | $55 |
Paid to pharmacies, not to this prescriber.
Other urogynecology and reconstructive pelvic surgery in Tulsa
- Karen GoldTulsa$1K
- Dena O LearyEdmond$35K
- Benjamin BarenbergOklahoma City$33K
- Lieschen QuirozOklahoma City$32K
- Adam HareOklahoma City$9K
- Stephanie PickettEdmond$8K
- Gini IkwuezunmaOklahoma City$7K
- Aleeza AbbasiOklahoma City$7K
- Arielle AllenOklahoma City$5K
- Edgar LeclaireEdmond$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.